Recent advances in Pediatric Vasculitis

Speciality: Pediatrics


Speaker:

Dr Sathish Kumar T | Pediatric clinical immunology and Rheumatology

Dr Murugan Sudhakar | Pediatric clinical immunology and Rheumatology

Description:

A warm welcome to all the medical professionals in this interesting session on recent advances in pediatric vasculitis.

Pediatric vasculitis has seen significant advancements in recent years, particularly in understanding the role of genetics and the immune system. Researchers have identified genetic factors linked to the susceptibility of certain vasculitis types, such as Kawasaki disease, improving early diagnosis and personalized treatment.

In treatment, biologic therapies, especially those targeting specific immune pathways like TNF inhibitors and IL-1 blockers, have shown promise in managing vasculitis more effectively. These treatments provide new options for patients unresponsive to conventional therapies.

Another breakthrough is the development of non-invasive imaging techniques, such as advanced MRI and PET scans, which allow for better monitoring of disease activity and response to therapy, reducing the need for invasive procedures like biopsies.

Collaborative efforts through global registries and research networks are also helping to gather more data on pediatric vasculitis. This has led to more standardized diagnostic criteria and treatment protocols, enhancing outcomes for young patients.

Lastly, improved awareness and education among healthcare providers have resulted in earlier recognition and intervention, preventing long-term complications. This progress represents a hopeful outlook for managing pediatric vasculitis in the coming years.

Therefore, get an overall knowledge of recent advances in pediatric vasculitis. Lis

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.

2.

A prostate cancer risk prediction algorithm could help target men at highest risk

3.

The way that miR-377 inhibits cells that cause prostate cancer.

4.

In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?

5.

Study indicates that exercise can help colon cancer survivors live as long as matched individuals


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot